FGF21 and obesity disorder: In an animal experiment, the administration of BMP9 into obese mice expresses enhanced gene expression of fibroblast growth factor 21 (FGF21), which is a metabolic regulator, and reduced a spectrum of pathological symptoms caused by high-fat diet- (HFD-) induced obesity [51].